Max Kappenstein

3PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 13, 2026
Real-World Efficacy and Safety of Lenvatinib and Sorafenib in Thyroid Cancer: A Retrospective, Propensity-Score-Matched Study.

Max Kappenstein, Viktoria Florentine Koehler, Nadia Ninosu

Pageof 1